Identification of a key transcriptional regulator of AT1 cell development and maintenance
AT1细胞发育和维持的关键转录调节因子的鉴定
基本信息
- 批准号:9397917
- 负责人:
- 金额:$ 3.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-04 至 2020-08-03
- 项目状态:已结题
- 来源:
- 关键词:AGTR2 geneAcute Lung InjuryAdoptionAdultAffectAlveolarAreaAttentionBinding SitesBloodBreathingBronchopulmonary DysplasiaCell MaintenanceCell NucleusCell ShapeCellsChIP-seqDataDevelopmentDiffusionDiseaseEnhancersEpigenetic ProcessFutureGasesGenesGenetic ModelsGenetic TranscriptionGenomicsGoalsGrowthHomeoboxHyperoxiaIntestinesInvestigationKnock-outLeftLiverLungLung diseasesMaintenanceMapsModelingMorphologyMusPerinatalPhysiologicalPulmonary PathologyReportingRoleSideStomachStreamSurfaceTestingTranscriptional Regulationcell typecellular imagingexperimental studygastrointestinalimaging modalitylung developmentlung injurymouse modelmutantpromotertranscription factortranscriptome sequencing
项目摘要
Project Summary
Despite the essential role of alveolar type 1 (AT1) cells in gas exchange, the AT1 cell has not received much
attention within the context of lung development, maintenance, and disease. We found that AT1 specific
deletion of the transcription factor NK homeobox2.1 (NKX2.1) during development results in loss of three
defining features of AT1 cells, as well as adoption of an alternative cell fate. This led to our hypothesis that
NKX2.1 is a key transcriptional regulator of development and maintenance of AT1 cells. We will investigate the
epigenetic mechanisms of NKX2.1 dependent transcriptional control in developing AT1 cells (aim 1) and
determine the role of NKX2.1 in mature AT1 cells as well as its contribution to lung injury (aim 2). Successful
completion of this study will elucidate the first transcription factors known to regulate AT1 development and
maintenance, paving the way for future investigation of AT1 cells in lung development and disease.
.
项目摘要
尽管肺泡1型(AT 1)细胞在气体交换中起着重要作用,但AT 1细胞并没有接受太多的气体交换。
在肺发育、维护和疾病的背景下关注。我们发现AT1特异性
在发育过程中,转录因子NK同源框2.1(NKX2.1)的缺失导致三个转录因子的丢失。
定义AT1细胞的特征,以及采用替代细胞命运。这导致了我们的假设,
NKX2.1是AT1细胞发育和维持的关键转录调节因子。我们将调查
发育中的AT1细胞中NKX2.1依赖性转录控制的表观遗传机制(目的1),
确定NKX2.1在成熟AT 1细胞中的作用以及其对肺损伤的贡献(目的2)。成功
这项研究的完成将阐明第一个已知的调节AT1发育的转录因子,
维持,为未来研究AT1细胞在肺发育和疾病中的作用铺平了道路。
.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Danielle R Little其他文献
Danielle R Little的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Danielle R Little', 18)}}的其他基金
Identification of a key transcriptional regulator of AT1 cell development and maintenance
AT1细胞发育和维持的关键转录调节因子的鉴定
- 批准号:
9754254 - 财政年份:2017
- 资助金额:
$ 3.1万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 3.1万 - 项目类别: